|
|
||||||||
Division of Pulmonary Biology, Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039
We increased surfactant pool size by surfactant treatment in mice to test if the catabolism of the major component of surfactant, saturated phosphatidylcholine (Sat PC), was rate limited. By intratracheal instillation, we gave mice trace doses, doses of 45 or 110 µmol/kg, or three doses of 110 µmol/kg of Sat PC in surfactant that contained radiolabeled dipalmitoylphosphatidylcholine (DPPC) and a radiolabeled phospholipase A-resistant ether analog of DPPC. Two strains of mice with 2-fold differences in alveolar and total Sat PC pool sizes were used; the mice with the higher pool sizes had a 2.3-fold higher steady-state catabolic rate. Acute increases in alveolar surfactant given by intratracheal instillation increased catabolic rates ~2-fold over the steady-state rates in both strains. There was minimal loss of the ether analog of DPPC from the lungs, and the alveolar macrophages did not accumulate more than 10% of the ether analog. In these two strains of mice, the catabolism of Sat PC was not rate limited because catabolic rate increased when alveolar pool sizes were increased.
surfactant treatment; dipalmitoylphosphatidylcholine; alveolar macrophage
This article has been cited by other articles:
![]() |
S. R. Bates, C. Dodia, J.-Q. Tao, and A. B. Fisher Surfactant protein-A plays an important role in lung surfactant clearance: evidence using the surfactant protein-A gene-targeted mouse Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L325 - L333. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jain, E. Atochina-Vasserman, H. Kadire, Y. Tomer, A. Inch, P. Scott, R. C. Savani, A. J. Gow, and M. F. Beers SP-D-deficient mice are resistant to hyperoxia Am J Physiol Lung Cell Mol Physiol, April 1, 2007; 292(4): L861 - L871. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Cogo, G. M. Toffolo, A. Gucciardi, A. Benetazzo, C. Cobelli, and V. P. Carnielli Surfactant disaturated phosphatidylcholine kinetics in infants with bronchopulmonary dysplasia measured with stable isotopes and a two-compartment model J Appl Physiol, July 1, 2005; 99(1): 323 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jain, C. Dodia, S. R. Bates, S. Hawgood, F. R. Poulain, and A. B. Fisher SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L759 - L765. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gurel, M. Ikegami, Z. C. Chroneos, and A. H. Jobe Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1266 - L1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Kramer, A. H. Jobe, and M. Ikegami Exogenous surfactant changes the phenotype of alveolar macrophages in mice Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L689 - L694. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |